Cancer-related immune antigens in the tumor microenvironment could represent an obstacle to agents targeting EGFR "cetuximab" or VEGF "bevacizumab" in metastatic colorectal cancer (mCRC) patients.
Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer
Parcesepe, Pietro;REMO, Andrea;BONETTI, Andrea;MANFRIN, Erminia;Ghasemi, Somayehsadat;BAZZONI, Flavia;
2015-01-01
Abstract
Cancer-related immune antigens in the tumor microenvironment could represent an obstacle to agents targeting EGFR "cetuximab" or VEGF "bevacizumab" in metastatic colorectal cancer (mCRC) patients.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2015_JExpClinCancerRes_Giordano et al.pdf
solo utenti autorizzati
Descrizione: Articolo principale
Tipologia:
Documento in Post-print
Licenza:
Accesso ristretto
Dimensione
2.55 MB
Formato
Adobe PDF
|
2.55 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
